Overdue for a refresh — no successor announced yet. Prices should be at their lowest
Best for: Android or iPhone users who want a balanced smartwatch with solid Fitbit health tracking, multi-day battery, and a clean square watch design — without the premium price of a Galaxy Watch or Apple Watch.
Full details →Reaching maturity, next model expected soon
Best for: iPhone users who want the most capable smartwatch health experience available. Ideal for anyone who values medical-grade monitoring (ECG, blood pressure, SpO2), a premium always-on display, and the best Apple Watch workout tracking. If health is your priority, this is the one to get.
Full details →| Fitbit Versa | Apple Watch | |
|---|---|---|
| Tier | Smartwatch | Smartwatch |
| Platform | iOS & Android | iOS only |
| Battery | 6 days | 1 days |
| Always-on display | ❌ | ✅ |
| GPS | ✅ | ✅ |
| Cellular | ❌ | ✅ |
| Health sensors | spo2, hr, hrv, eda stress | ecg, spo2, skin temp, hrv, blood pressure |
| Released | Sep 25, 2022 | Sep 19, 2025 |
| Cycle length | 730 days | 364 days |
| Cycle advice | bad | neutral |
| Deals advice | good | neutral |
| Next model | — | Apple Watch Series 12 (Expected fall 2026) |
Rare for a smartwatch with real GPS and health sensors to work fully on both platforms — Versa 4 does.
Turn-by-turn navigation and NFC payments without needing your phone in hand.
Sleep stages, daily readiness score, Active Zone Minutes, and SpO2 — all on a 6-day charge.
The Series 11 is the first mainstream smartwatch to offer FDA-cleared hypertension (high blood pressure) detection — a feature that could flag silent health risks.
At 9.7mm, the Series 11 is significantly slimmer than previous models — noticeably lighter on the wrist for all-day and sleep tracking.
On-demand ECG, continuous blood oxygen monitoring, and sleep apnea detection (FDA-cleared) make this one of the most medically relevant consumer wearables available.